Cronos Group Income Taxes 2017-2025 | CRON

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cronos Group income taxes from 2017 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cronos Group income taxes from 2017 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$80.2B
Zoetis (ZTS)	$68.3B
Daiichi Sankyo, - (DSNKY)	$47.1B
Takeda Pharmaceutical (TAK)	$46.9B
BeOne Medicines - (ONC)	$32.3B
Sandoz Group AG (SDZNY)	$26.4B
Summit Therapeutics (SMMT)	$20.8B
Merck (MKKGY)	$17.3B
Shionogi (SGIOY)	$14.5B
United Therapeutics (UTHR)	$13.8B
Neurocrine Biosciences (NBIX)	$13.2B
Orion OYJ (ORINY)	$11.7B
IPSEN (IPSEY)	$10.9B
Stevanato Group S.p.A (STVN)	$7.7B
Corcept Therapeutics (CORT)	$7.3B
Madrigal Pharmaceuticals (MDGL)	$6.8B
Grifols, S.A (GRFS)	$6.8B
Ionis Pharmaceuticals (IONS)	$6.7B
Hikma Pharmaceuticals Plc (HKMPF)	$5.9B
Ono Pharmaceutical (OPHLF)	$5.2B
Soleno Therapeutics (SLNO)	$4.4B
Hypermarcas (HYPMY)	$3.1B
Crinetics Pharmaceuticals (CRNX)	$2.9B
NewAmsterdam Pharma (NAMS)	$2.7B
Catalyst Pharmaceuticals (CPRX)	$2.6B
Procaps Group, S.A (PROCF)	$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.5B
Centessa Pharmaceuticals (CNTA)	$2.1B
Ocular Therapeutix (OCUL)	$1.9B
BioCryst Pharmaceuticals (BCRX)	$1.8B